The first Chinese medicine Qingfei Sanjie pill for lung cancer

This is the first Chinese patent medicine recognized as having therapeutic effect in the field of cancer treatment According to a person in charge of Hainan Institute of drug control, with the implementation of the new edition of the national pharmacopoeia, some Chinese patent medicines with definite curative effects have been identified in some specialized fields, and will also guide enterprises to actively carry out relevant clinical verification It is reported that Qingfei Sanjie pill completed clinical research in more than 30 hospitals above the third grade On May 27, 2014, the State Food and Drug Administration and the State Pharmacopoeia Commission revised the functional indications of the variety The revised functional indications are: clearing the lung, dispersing the knots, promoting blood circulation, relieving pain, detoxifying and resolving phlegm It can also be used as an auxiliary drug for lung cancer surgery, radiotherapy and chemotherapy For enterprises keen to improve standards, a director of Guangyao Group Pharmaceutical Research Institute said that, on the one hand, brand enterprises hope to improve the threshold of product imitation by improving standards, and create new amulets for brand Chinese medicine; on the other hand, through standard change, they can apply for or change new indications for Chinese medicine to meet the market demand Zhou Wenqian, chairman of Hainan longshengtang Pharmaceutical Co., Ltd., said that at present, the pressure of medical insurance payment in China is increasing, because the price of treatment courses is low, and the advantages of Chinese patent medicine in the field of cancer treatment are very obvious At present, the company is in contact with medical insurance centers in many provinces and cities, and is expected to add Qingfei Sanjie pill to the coverage of serious illness insurance reimbursement for lung cancer.